These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Advances in the use of iron-chelating agents for the treatment of iron overload. Modell B Prog Hematol; 1979; 11():267-312. PubMed ID: 392593 [No Abstract] [Full Text] [Related]
5. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia]. Cario H; Grosse R; Janssen G; Jarisch A; Meerpohl J; Strauss G; Klin Padiatr; 2010 Nov; 222(6):399-406. PubMed ID: 20862634 [TBL] [Abstract][Full Text] [Related]
6. Impact of transfusion dependency and secondary iron overload on the survival of patients with myelodysplastic syndromes. Malcovati L Leuk Res; 2007 Dec; 31 Suppl 3():S2-6. PubMed ID: 18037415 [TBL] [Abstract][Full Text] [Related]
7. Antioxidant micronutrients in children with thalassaemia in Egypt. Nasr MR; Ali S; Shaker M; Elgabry E East Mediterr Health J; 2002; 8(4-5):490-5. PubMed ID: 15603029 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of iron overload by phlebotomies in a patient with severe congenital dyserythropoietic anemia type II. Hofmann WK; Kaltwasser JP; Hoelzer D; Nielsen P; Gabbe EE Blood; 1997 Apr; 89(8):3068-9. PubMed ID: 9108433 [No Abstract] [Full Text] [Related]
9. Iron: The fifth horseman of the apocalypse? DeLoughery TG Am J Hematol; 2009 May; 84(5):263-4. PubMed ID: 19358299 [No Abstract] [Full Text] [Related]
10. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias. Pippard MJ; Weatherall DJ Haematologia (Budap); 1984; 17(1):17-24. PubMed ID: 6724353 [TBL] [Abstract][Full Text] [Related]
11. A case of rhesus hemolytic disease with hemophagocytosis and severe iron overload due to multiple transfusions. Yilmaz S; Duman N; Ozer E; Kavas N; Oren H; Demircioğlu F; Kumral A; Ozkan H; Irken G; Ozer E J Pediatr Hematol Oncol; 2006 May; 28(5):290-2. PubMed ID: 16772878 [TBL] [Abstract][Full Text] [Related]
13. Management of iron overload in the pediatric patient. Cohen A Hematol Oncol Clin North Am; 1987 Sep; 1(3):521-44. PubMed ID: 3329185 [TBL] [Abstract][Full Text] [Related]
14. Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines. Mittelman M; Lugassy G; Merkel D; Tamary H; Sarid N; Rachmilewitz E; Hershko C; ; Isr Med Assoc J; 2008 May; 10(5):374-6. PubMed ID: 18605364 [No Abstract] [Full Text] [Related]
15. Recognition and treatment of iron overload. Brown EB Adv Intern Med; 1980; 26():159-86. PubMed ID: 7013439 [No Abstract] [Full Text] [Related]
17. Concepts and goals in the management of transfusional iron overload. Porter JB Am J Hematol; 2007 Dec; 82(12 Suppl):1136-9. PubMed ID: 17968973 [TBL] [Abstract][Full Text] [Related]
18. Unrelated hematopoietic stem cell transplantation in a patient with congenital dyserythropoietic anemia and iron overload. Buchbinder D; Nugent D; Vu D; Soni A; Stites J; Hsieh L; Puthenveetil G Pediatr Transplant; 2012 May; 16(3):E69-73. PubMed ID: 21108711 [TBL] [Abstract][Full Text] [Related]
19. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Chacko J; Pennell DJ; Tanner MA; Hamblin TJ; Wonke B; Levy T; Thomas PW; Killick SB Br J Haematol; 2007 Sep; 138(5):587-93. PubMed ID: 17610536 [TBL] [Abstract][Full Text] [Related]
20. [Hepcidin: the Grail of iron metabolism]. Loréal O; Brissot P Gastroenterol Clin Biol; 2002; 26(8-9):805-7. PubMed ID: 12434091 [No Abstract] [Full Text] [Related] [Next] [New Search]